Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Chao

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of the National Cancer Institute|March 13, 2018
Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based TestingHuma Q Rana, Rebecca Gelman, Holly LaDuca, et al.
Journal of Medical Genetics|August 9, 2019
Tumour characteristics provide evidence for germline mismatch repair missense variant pathogenicityShuwei Li, Dajun Qian, Bryony A Thompson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 21, 2010
Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancerSteven M Lipkin, Elizabeth C Chao, Victor Moreno, et al.
Scientific Reports|September 6, 2019
REVEL and BayesDel outperform other in silico meta-predictors for clinical variant classificationYuan Tian, Tina Pesaran, Adam Chamberlin, et al.
Plos One|May 17, 2014
The validation and clinical implementation of BRCAplus: a comprehensive high-risk breast cancer diagnostic assayHansook Kim Chong, Tao Wang, Hsiao-Mei Lu, et al.
Breast Cancer Research and Treatment|December 24, 2016
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected resultsMary Pritzlaff, Pia Summerour, Rachel McFarland, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 17, 2017
Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVarSteven M Harrison, Jill S Dolinsky, Amy E Knight Johnson, et al.
Cancer Genetics|May 21, 2018
Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalentZöe Powis, Carin R Espenschied, Holly LaDuca, et al.
JAMA Oncology|November 4, 2023
Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer TestingCarolyn Horton, Lily Hoang, Heather Zimmermann, et al.
Human Mutation|April 3, 2008
Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR)Elizabeth C Chao, Jonathan L Velasquez, Mavee S L Witherspoon, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|March 13, 2018
Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based TestingHuma Q Rana, Rebecca Gelman, Holly LaDuca, et al.
Journal of Medical Genetics|August 9, 2019
Tumour characteristics provide evidence for germline mismatch repair missense variant pathogenicityShuwei Li, Dajun Qian, Bryony A Thompson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 21, 2010
Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancerSteven M Lipkin, Elizabeth C Chao, Victor Moreno, et al.
Scientific Reports|September 6, 2019
REVEL and BayesDel outperform other in silico meta-predictors for clinical variant classificationYuan Tian, Tina Pesaran, Adam Chamberlin, et al.
Plos One|May 17, 2014
The validation and clinical implementation of BRCAplus: a comprehensive high-risk breast cancer diagnostic assayHansook Kim Chong, Tao Wang, Hsiao-Mei Lu, et al.
Breast Cancer Research and Treatment|December 24, 2016
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected resultsMary Pritzlaff, Pia Summerour, Rachel McFarland, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 17, 2017
Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVarSteven M Harrison, Jill S Dolinsky, Amy E Knight Johnson, et al.
Cancer Genetics|May 21, 2018
Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalentZöe Powis, Carin R Espenschied, Holly LaDuca, et al.
JAMA Oncology|November 4, 2023
Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer TestingCarolyn Horton, Lily Hoang, Heather Zimmermann, et al.
Human Mutation|April 3, 2008
Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR)Elizabeth C Chao, Jonathan L Velasquez, Mavee S L Witherspoon, et al.
Pageof 4